Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Relapsed/Refractory Hodgkin Lymphoma - Salvage Treatments, Nivolumab and Pembrolizumab Trials and CAR-T Cell Therapy
Login to view comments.
Click here to Login
Malignant Hematology